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Summary: 2,3-Dihydroxybutane, a compound not observed in normal urines, was identified in the urine of two
patients by combined gas chromatography-mass spectrometry. It is suggested, that this 2,3-dihydroxybutane is
derived from pyruvate by bacterial metabolism.
2,3-Dihydroxybutan: Eine ungewöhnliche Verbindung, gefunden beider gaschromatographischen Analyse flüchtiger
Verbindungen des Harns
Zusammenfassung: 2,3-Dihydroxybutan, eine im normalen Harn nicht beobachtete Verbindung, wurde durch Gas-
chromatographie-Massenspektrometrie im Harn zweier Patienten identifiziert. Es wird angenommen, daß 2,3-
Dihydroxybutan durch bakteriellen Stoffwechsel aus Pyruvat entsteht.
Introduction
Gas chromatography has proved to be a powerful tech-
nique for the identification of normal and abnormal
metabolites in human body fluids and urine. In most
cases compounds can be identified as being derived from
normal or deranged human metabolism, but some ex-
amples are known of compounds in urine whose origin
must be exogenous (1—4), the latest additions to this
list being laevulinic acid (5) and 2-ethpxy-ethoxy-acetic
acid (6). In this communication the identification of
2,3-dihydroxybutane is described.
Materials and Methods
Patients
Case 1 (patient R.) was born after an uneventful pregnancy with
a birth weight of 2510 g. Except for increased muscle tone and
irritability no abnormalities were noted. Blood levels of glucose,
calcium and magnesium were normal. When the child was 9 days
old he became apathetic and vomited. No cause was found and
he recovered rapidly after the modified milk feedings had been
substituted by intravenous glucose and fat emulsions. Blood and
urine examinations were normal, except for a low urea level
(blood urea nitrogen 47 mg/1), a slightly increased ammonia
level (1.8 mg/1) and a metabolic acidosis (pH 7.30). Amino acids
were normal as was urinary lactate excretion. After 2 days, oral
feeding was reinstituted, and the clinical condition was satis-
factory, although increased muscle tone and irritability per-
sisted. Concentrations of amino acids and pyruvate in cere-
brospinal fluid were within normal limits. During the following
weeks repeated blood investigations all gave normal results, but
the unexplained metabolic acidosis persisted for 2 weeks.
Diarrhoea never occurred. During this period, a 24 hour urine
sample was sent to the laboratory for investigation of organic
acids and 2,3-dihydroxybutane was then detected. Without
further treatment the acidosis disappeared and the child was
discharged. During follow-up he did well and after 2*/2 months
muscle tone became normal. Development was unimpaired.
Case 2 was born after a pregnancy of 33 weeks, with a birth
weight of 1800 g. A metabolic acidosis (pH 7.20) was observed
during the first week of life which was corrected with intra-
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venous sodium hydrogencarbonate. All other clinical chemical
parameters, which included blood amino acids, blood lactate
and pyruvate and glucose, were within normal limits. During
this period of acidosis, urine was analysed for organic acids and
2,3-dihydroxybutane was found. The child was slightly
apathetic. The acidosis disappeared without further treatment
and the child was discharged after two weeks. After the period
of acidosis, the 2,3-dihydroxybutane could not be detected
again in the urine.
Procedure
Volatile and non volatile comuounds of urine were analysed as
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described previously (7,8). Urines were stored at -70°C until
analysis. Mass spectrometry was carried out on a Finnigan 3300
GCMS system equipped with the standard all glass jet separator
and standard electron impact source. A 2.2 m X 2 mm i.d. glass
column packed with 20% NPGA and 2% HaPC^ on Gas Chrom
Q 80-100 mesh was used with He as the carrier gas at 30 ml/
min. Mass spectra were processed by the Finnigan 6100 data
system.
Results and Discussion
Figure 1 shows the gas chromatogram of the volatile
compounds of the urine of the first patient. Besides
small amounts of formic acid, acetic acid and propionic
acid with retention times of 0.19, 0.22 and 0.36
respectively, with respect to the internal standard (2-
methyl-n-butyric acid), a large fraction with a retention
time of 0.62 can be observed. This fraction is asymmetric.
The column used for the identification of volatile
components in urine (7) has however been designed
primarily for the analysis of short chain fatty acids.
Mass spectrometry identified this compound as 2,3-
dihydroxy-butane, as is illustrated in figure 2. The mass
spectrum of the compound with retention time 0.62
(fig. 2 top) was identical to that of authentic 2,3-
dihydroxybutane (fig. 2 bottom). Authentic 2,3-dihydro-
xybutane yielded a gas chromatogram identical to that
given by the urine fraction with a relative retention time
of 0.62, and the same typical peak asymmetry. The
molecular weight of 2,3-dihydroxybutane is 90. The
peaks, observed in the mass spectrum with m/e values
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Fig. 1. Gas chromatogram of the volatile compounds of the
urine of the first patient. I. St. = Internal standard = 2-
ethyl-w-butyric acid.
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Fig. 2. Mass spectra of the compound of the gas chromatogram
of figure 1 with relative retention time of 0.62 (top) and
of authentic 2,3-dihydroxybutane (bottom). Cleavage of
the C2~C3 bond produces the base peak at m/e 45.
Peaks > 60 are magnified 10 times.
higher than 90, are due to column bleeding. The mass
spectrum of the urinary compound with a relative
retention time of 0.62, the spectrum of an authentic
sample of 2,3-dihydroxybutane, and the published
mass spectrum of 2,3-dihydroxybutane (9) were
identical.
No other abnormal metabolites were observed in the
patient's urine by gas chromatography for volatile or non
volatile compounds. The gas chromatpgram of the
volatile compounds of the urine of the second patient
was virtually identical to that of the first patient. The
gas chromatogram of the nonvolatile compounds yielded
likewise no indication for the presence of abnormal
metabolites, except for the trimethylsilyl derivative of
2,3-dihydroxybutane. The 2,3-dihydroxybutane could
be of bacterial origin. Several bacteria, including JE. coli
contain acetoläctate synthetase, which converts pyruvate
to acetoläctate. This acetoläctate is decarboxylated to
acetoin which can be reduced to the diol by butanediol
dehydrogenase (for review c.f. Lc. (10)). The mammalian
liver is, however, also able to form acetoin from pyruvate
or ethanol (11-13) via the action of pyruvate decarboxy-
lase; furtherrhore, acetoin can be reduced to 2,3-dihy-
droxybutane (13). It could be speculated that an over-
flow of the pyruvate decarboxylase reaction results in
the formation of acetoin and 2,3-dihydroxybutane.
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Since both patients developed normally, the occurrence
of 2,3-dihydroxybutane does not seem to be harmful.
During the investigation of patients suspected of inborn
errors of metabolism unknown compounds are fre-
quently observed in the gas chromatograms of urine or
blood. The determination of the structure is essential
because of its possible endogenous origin, which may
give a clue to the nature of the defect. Future evaluation
of gaschromatograms have now to take into account the
possible occurrence of 2,3-dihydroxybutane, which is
presumably of exogenous origin.
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